CHARACTERISTICS AND PROGNOSIS OF HORMONE RECEPTOR POSITIVE AND HER2 NEGATIVE RECURRENT BREAST CANCER PATIENTS RECEIVING POSTOPERATIVE AROMATASE INHIBITOR

被引：0
|
作者：
Mayumi, Ishida [1 ]
Akiko, Igawa [1 ]
Akihiro, Saruwatari [1 ]
Masahiro, Oikawa [1 ]
Chinami, Koga [1 ]
Sumiko, Nishimura [1 ]
Yumiko, Koi [1 ]
Sayuri, Akiyoshi [1 ]
Yoshiaki, Nakamura [1 ]
Shinji, Ohno [1 ]
机构：
[1] Kyushu Natl Canc Ctr, Fukuoka, Japan
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
10.1016/S0960-9776(13)70098-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S48 / S49
页数：2
相关论文
共 50 条
  • [31] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
  • [32] HER2 up-regulation with neoadjuvant endocrine therapy in patients with hormone receptor-positive, HER2-negative breast cancer
    Chaudhary, Lubna N.
    Jorns, Julie
    Gonyo, MaryBeth
    Kong, Amanda
    Peck, Amy R.
    Sun, Yunguang
    Bergom, Carmen
    Banarjee, Anjishnu
    Chitambar, Christopher
    Rui, Hallgeir
    CANCER RESEARCH, 2020, 80 (04)
  • [33] Validation of Magee equation in predicting response to neoadjuvant chemotherapy in breast cancer patients with hormone receptor positive and HER2 negative
    Saigosoom, N.
    O-charoenrat, P.
    Udompunturak, S.
    Sanguanraksa, D.
    BREAST, 2019, 44 : S73 - S73
  • [34] Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer
    Pegram, Mark
    Jackisch, Christian
    Johnston, Stephen R. D.
    NPJ BREAST CANCER, 2023, 9 (01)
  • [35] Benefits of capecitabine in hormone receptor-positive compared to hormone receptor-negative HER2 normal metastatic breast cancer
    Altundag, Kadri
    MEDICAL ONCOLOGY, 2024, 41 (06)
  • [36] Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer
    Mark Pegram
    Christian Jackisch
    Stephen R. D. Johnston
    npj Breast Cancer, 9
  • [37] Surgical Management of the Axilla in Patients Presenting with Clinically Node Positive Hormone Receptor Positive, HER2 Negative (HR+/HER2-) Breast Cancer
    Jasper, Jacob
    Kantor, Olga
    Dorninici, Laura
    Nakhlis, Faina
    Ogayo, Esther
    Nimbkar, Suniti
    Kurt, Busem Binbogct
    King, Tari
    Mittendorf, Elizabeth
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S101 - S101
  • [38] Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape
    Beith, Jane
    Burslem, Katie
    Bell, Richard
    Woodward, Natasha
    Mccarthy, Nicole
    De Boer, Richard
    Loi, Sherene
    Redfern, Andrew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 3 - 18
  • [39] Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
    Ballinger, Tarah J.
    Meier, Jason B.
    Jansen, Valerie M.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [40] A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer
    Ardavanis-loukeris, Gerasimos
    Kokkali, Stefania
    Perdikari, Konstantina
    Karatrasoglou, Eleni
    Talagani, Sofia
    Tzovaras, Alexandros
    Ardavanis, Alexandros
    ANTICANCER RESEARCH, 2024, 44 (04) : 1559 - 1565
12345